About This Report

Carotid Stents Market, by Type (Balloon-Expandable Stents, and Self-Expanding Stents), by Material (Metals, and Others), by End-User (Cardiac Centres, Hospitals, and Ambulatory Surgical Centres), and by Region (North America, South America, Europe, Asia Pacific, The Middle East, and Africa) - Size, Share, COVID Impact Analysis, Growth, Outlook, and Opportunity Analysis, 2020 - 2028

Carotid stents are tiny, mesh-like tubes that are inserted into the carotid artery to treat carotid artery disease. The carotid artery is the principal artery supplying blood to the brain. A plaque build-up in this artery may cause it to narrow or get blocked, leading to a stroke. Patients who are not seen to be suitable candidates for carotid endarterectomy, a surgical technique that requires the removal of the plaque from the carotid artery, frequently undergo carotid stenting. When compared to carotid endarterectomy, carotid stenting is less surgical and can be used to treat patients at high risk for subsequent problems, such as those with lung or heart illness. Patients with carotid artery disease who are not suitable surgical candidates are able to get safe and efficient treatment with carotid stenting.

In 2020, the Carotid Stents market was valued at US$ YY million, and it is anticipated to be around US$ YY million by 2027. Over the forecast period, the market is expected to grow at a CAGR of YY%.

Technological advancements and Increasing prevalence of carotid artery disease drive the Carotid Stents market, while Potential complications pose a hindrance to its growth

The incidence of carotid artery disease is growing as a result of ageing populations, unhealthy lifestyles, and rising rates of diabetes and obesity. For instance, The American Heart Association reported that stroke is the fifth most common cause of death in the country, and that 87% of all strokes are ischemic strokes brought on by blood channel blockages. Additionally, a study that reported in the Vascular Surgery Journal predicts that the rate of carotid artery disease in the US will rise from 3.9% in 2010 to 4.6% in 2030 as a result of a growing elderly population and increased rates of health risks involving obesity and diabetes. Furthermore, Significant improvements in stent design, deployment mechanisms, and imaging methods have all been made in carotid stenting technology. These innovations have raised success rates and decreased problems. For instance, The FDA approved the CGuard Embolic Prevention System in 2020. This device uses a micro-net to capture and remove plaque and debris during the stenting procedure, reducing the risk of stroke.

However, Carotid stenting involves a number of challenges, including bleeding, infection, and harm to the artery or adjacent tissue. Occasionally, the stent can break or the artery might get blocked subsequently, requiring additional medical care. For instance, in comparison to carotid endarterectomy, carotid stenting had a somewhat higher risk of stroke and mortality, according to a review article published in Stroke and Vascular Neurology.

Self-expandable stents segment is expected to account for significant market share by Type segment

The global Carotid Stents market is mainly classified by Type, Material, and End-User. Type is segmented into balloon-expandable stents, and self-expandable stents. By Material, the market is categorised into metals, and others. Metals are further classified into cobalt chromium, platinum chromium, nickel titanium, and stainless steel. On the basis of End-User, the segment is divided into cardiac centres, hospitals, and ambulatory surgical centres.
On the basis of Type, the self-expandable stents are anticipated to account for a sizable portion of the Carotid Stents market, due to a number of factors like superior features, and technological advancements. For instance, businesses like Medtronic and Abbott Laboratories have created inventive self-expanding stents with better delivery systems and designs. An illustration of such a device is the self-expanding Carotid Stent System from Medtronic, which has an open-cell design that allows it to adjust to the geometry of the artery and prevent plaque build-up. Besides, Self-expanding stents are safe and efficient for the treatment of carotid artery disease, according to a number of studies. For instance, according to a study by Journal of Endovascular Therapy, compared to balloon-expandable stents, self-expanding stents had a greater technical success rate and a reduced incidence of perioperative problems.

Interesting Facts of Carotid Stents Market

• By end-user classification, the hospital area commands a sizable share in the carotid stents market. The increase in patients obtaining medical care in surroundings with up-to-date infrastructure and adequate facilities is primarily the reason for this.
• The largest portion of the market was handled by the nickel-titanium alloy sector. It has important uses in medical devices as its special qualities allows individuals to have better quality of life through fewer procedures and implants. Additionally, the market has grown due to its outstanding qualities, which include corrosion resistance, biological compatibility, more adaptability, and heat resistance.
• In the years to come, the Asia Pacific market for carotid stents is anticipated to expand quickly due to a number of factors, including improved healthcare infrastructure, an increase in the prevalence of carotid artery disease, and rising healthcare spending.
• The commercialization of modern cardiovascular technologies has been handled by a number of top medical technology companies based in North America. For instance, Medtronic, a US-based manufacturer of medical devices, is one of the market's major competitors and offers a variety of products for the detection, treatment, and management of cardiovascular illnesses.
• North America holds the largest market share of the Carotid Stents industry.

Cardiovascular diseases are a prominent cause of mortality and morbidity worldwide, and North America is one of the regions with the highest frequency of these illnesses. For instance, approximately 840,000 deaths in the United States are caused by cardiovascular disease each year, according to the American Heart Association, more than all types of cancer combined. With the United States being the third-most populous nation in the globe, North America also possesses a large population. With such a vast population base, there is a sizable market for healthcare goods and services, especially those connected to the identification, treatment, and control of cardiovascular conditions.

The high level of healthcare spending and well-developed healthcare infrastructure in North America also make it possible to use cutting-edge technologies for the detection and treatment of cardiovascular disorders. Leading medical technology developers and pharmaceutical firms that are engaged in the commercialization of innovative cardiovascular technologies can be found throughout the region. For instance, The World Bank reports that the United States spent the most on healthcare among OECD nations in 2019—17.7% of GDP. Cardiovascular disease is one of the leading causes of healthcare expense in the United States, where it is anticipated that total national healthcare spending will exceed $4 trillion in 2020. A number of top pharmaceutical firms that work on the creation and marketing of medications to treat cardiovascular illnesses are based in North America. For instance, Pfizer, a US-based pharmaceutical business, is well-known in the market for cardiovascular medications owing to its offerings of Lipitor and Norvasc.

Global Carotid Stents Market key Players:

Some of the major competitors in the global Carotid Stents market include Abbott Laboratories, Cardinal Health, Medtronic Plc, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, BIOTRONIK SE & Co. KG, InspireMD, Impulse Dynamics, Boston Scientific Corporation, Beijing Bomais Technology Development, and Shanghai Zhenyu Biological Technology Co., Ltd.

• The Carotid Stents industry is extremely competitive with aggressive market strategies of global and regional companies looking to strengthen market position through new product launches and facility expansions. The following are some recent market developments:
• In February 2022, Medtronic released the Insertable Cardiac Monitoring System (ICM) called the MicraTM AV Reveal LINQTM. The device continuously assesses for the presence of the atrioventricular (AV) block, a condition that prevents electrical signals from passing between the heart's atria and ventricles.
• Edwards Lifesciences announced the official launch of their HemoSphere Advanced Monitoring Platform in October 2021. The platform's goal is to give doctors the information they need to make wise decisions regarding a patient's treatment by providing real-time data and insights on their cardiovascular health during surgery.
• In March 2021, Medtronic announced a partnership with Viz.ai, a well-known supplier of artificial intelligence software for stroke care, to incorporate Viz.ai's technology into Medtronic's stroke solutions. The efficiency and effectiveness of stroke care are anticipated to be improved by this collaboration.
• Leading medical device manufacturer Boston Scientific announced in February 2021 that it has purchased Preventice Solutions, a remote monitoring and diagnostics business specialising in the management of cardiac arrhythmias. Boston Scientific's portfolio of cardiovascular technology should become stronger as a result of this acquisition.

Frequently asked questions about global Carotid Stents market

Q: What is the current size of the global Carotid Stents market?
Ans: The Carotid Stents market was valued at YY Million US$ in 2020 and is projected to reach YY Million US$ by 2027, at a CAGR of YY% during the forecast period.

Q: What are the major opportunities in Carotid Stents industry?
Ans: The rising prevalence of carotid artery disease, rising acceptance of minimally invasive procedures, upgrading the healthcare infrastructure, increasing expenditure on healthcare, and the development of new and revolutionary technologies are some of the key opportunities in the carotid stents market.

Q: What is major growth driving factor for Carotid Stents industry?
Ans: The worldwide rise in carotid artery disease severity, which contributes to demand for carotid stents and other medical devices used to treat the illness, is the primary growth driver for the carotid stents industry.

Q: Which region is expected to have the largest share of the Carotid Stents market?
Ans: The North America region is anticipated to account for the largest share of the world market for Carotid Stents during the forecast period.

Q: Which end-user segment will dominate the Carotid Stents market?
Ans: Hospitals are anticipated to lead the carotid stents market since they are the primary healthcare providers that treat cardiovascular diseases like carotid artery disease.